Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

89 projects found matching your search criteria :

  1. Exploring Antimicrobial Potential of Mytilus Genomic Resources

    Call: OPUS 29 , Panel: NZ8

    Principal investigator: prof. Artur Stanisław Burzyński

    Instytut Oceanologii PAN

  2. Titanium Dioxide in a New Light: Reducing Toxicity and Improving the Photoprotective Properties of TiO2 Through Nanopart...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Michał Jan Gackowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  3. Hydrothermal surface phosphorylation as the key to the ideal implant – a new generation of implants capable of releasing...

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Marcel Jakubowski

    Politechnika Poznańska

  4. A new strategy to fight antibiotic resistance based on hybrids of fluoroquinolones and quaternary ammonium salts

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Joanna Dagmara Fedorowicz

    Gdański Uniwersytet Medyczny

  5. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  6. A new universal method for the isolation and deep proteomic characterization of extracellular vesicles to study drug res...

    Call: PRELUDIUM 23 , Panel: NZ2

    Principal investigator: Bianka Świderska

    Instytut Biochemii i Biofizyki PAN

  7. Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Piotr Wilk

    Uniwersytet Jagielloński

  8. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Monika Katarzyna Rola

    Politechnika Łódzka

  9. New functional MOF@hydroxyapatite composites for the treatment of bacterial bone infections

    Call: PRELUDIUM 23 , Panel: ST11

    Principal investigator: Weronika Bodylska

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

  10. Manufacture of a new generation three-dimensional "drug-on-chip" materials with controlled release of active agents dedi...

    Call: SONATINA 8 , Panel: ST8

    Principal investigator: dr Wiktoria Dominika Tomal

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  11. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Joanna Krystyna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  12. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  13. The effect of prolonged treatment with the new antipsychotics brexpiprazole and lumateperone on human liver function usi...

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii PAN

  14. Synthesis and application of new mixed-mode materials to study the metabolism of drugs used in Poland for the treatment ...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Studzińska

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  15. Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Krzysztof Nowicki

    Politechnika Warszawska, Wydział Chemiczny

  16. Computational alchemy and experimental validation: a hybrid approach for designing new antimicrobial peptides

    Call: PRELUDIUM 22 , Panel: NZ1

    Principal investigator: Piotr Maciej Chyży

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  17. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

  18. Exploring the unknown drug-like chemical space: new classes of sulfoximine derivatives and their biological activities.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Maciej Filip Dawidowski

    Warszawski Uniwersytet Medyczny

  19. The application of artificial intelligence to the discovery of new natural drugs with mechanisms aimed at lowering free ...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Maciej Spiegel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  20. The role of Candida albicans' plasma membrane sphingolipids in the potentially new mechanism of drug resistance and in t...

    Call: OPUS 22 , Panel: NZ1

    Principal investigator: dr hab. Anna Janina Krasowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  21. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  22. Cinemagoing in German-occupied Poland: Cinema programming and film preferences of multi-ethnic urban audiences during Wo...

    Call: OPUS 22 , Panel: HS2

    Principal investigator: dr hab. Andrzej Dębski

    Uniwersytet Wrocławski, Centrum Studiów Niemieckich i Europejskich im. Willy Brandta

  23. Rhizomatic networks, circulation of meanings and contents, and offline contexts of online drug trade

    Call: OPUS 22 , Panel: HS6

    Principal investigator: dr hab. Piotr Siuda

    Uniwersytet Kazimierza Wielkiego

  24. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii PAN

  25. Mitochondria-targeting conjugates as a new anticancer agents

    Call: OPUS 21 , Panel: ST4

    Principal investigator: prof. Adam Włodzimierz Huczyński

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  26. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  27. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Janusz Edward Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  28. New antimycotic polycations - synthesis, chemical characterization, toxicity and antifungal spectrum

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Kamil Krzysztof Kamiński

    Uniwersytet Jagielloński, Wydział Chemii

  29. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

  30. Tryptophan Metabolites and their Metal Complexes as new drugs for Colorectal Cancer Treatment and Human Gut Microbiota R...

    Call: OPUS 20 , Panel: ST4

    Principal investigator: prof. Beata Izabella Godlewska-Żyłkiewicz

    Uniwersytet w Białymstoku, Wydział Chemii

  31. New generation teranostatic nanocarriers for detection, diagnosis andneuroprotective treatment of ischemic stroke brain ...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Piotr Warszyński

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  32. The study on the molecular mechanisms of cytotoxic activity of new compounds ZOT5-1-Me and ZOT5-1-Et in an experimental ...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Paulina Anna Tokarz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  33. The new methodology for better understanding of ligand-RNA interactions.

    Call: OPUS 20 , Panel: NZ2

    Principal investigator: dr Filip Artur Stefaniak

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  34. Polymersomes specifically releasing cGAMP and doxorubicin in tumor hypoxic regions as a new anti-cancer therapeutic stra...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr hab. Ryszard Smolarczyk

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  35. Dissecting cancer activome to develop new generation of antibody-drug conjugates

    Call: OPUS 20 (LAP) , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  36. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  37. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

  38. Assessment of therapeutic value and usefulness of new generation antibiotics and their metabolites as resistance markers...

    Call: PRELUDIUM 19 , Panel: ST4

    Principal investigator: Katarzyna Joanna Pauter-Iwicka

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  39. Do potential new MRGPRX2 ligands induce mastocytes degranulation in human?

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Grzegorz Porębski

    Uniwersytet Jagielloński, Collegium Medicum

  40. Fluorine substitution – a new algorithm for increasing biological activity

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Wojciech Pietruś

    Instytut Farmakologii PAN

  41. Insulin – metallacarborane conjugates: A new strategy to enhance the biological efficacy of peptide drugs

    Call: PRELUDIUM BIS 1 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Marek Goszczyński

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  42. Gankyrin protein as a new potential therapeutic target in multiple myeloma

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Irena Misiewicz-Krzemińska

    Instytut Hematologii i Transfuzjologii

  43. Specific interactions of new antitumor unsymmetrical bisacridines, UAs, with DNA and ABC proteins and their potential to...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: prof. Zofia Mazerska

    Politechnika Gdańska

  44. DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr hab. Oleh M. Demchuk

    Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

  45. Metabolites of Baltic cyanobacteria as natural compound library for high throughput screening and the development of new...

    Call: OPUS 17 , Panel: NZ9

    Principal investigator: prof. Hanna Jurata Mazur-Marzec

    Uniwersytet Gdański, Wydział Chemii

  46. Anticancer Trojan horses: Application of the bioconjugation idea to invent new anticancer drugs

    Call: UWERTURA 3 , Panel: ST4

    Principal investigator: dr Michał Piotr Antoszczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  47. Evaluation of the effects of long-term administration of new anticonvulsant drug-candidate.

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Anna Łucja Makuch-Kocka

    Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

  48. Exploring second generation of nucleotide analogues containing phosphoranesulfen- or phosphoraneselenamides as new struc...

    Call: PRELUDIUM 16 , Panel: ST5

    Principal investigator: dr Justyna Gołębiewska

    Instytut Chemii Bioorganicznej PAN

  49. Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st...

    Call: OPUS 16 , Panel: NZ2

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

  50. Searching for new mechanisms of substance use or stress disoreders

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: dr Wojciech Solecki

    Uniwersytet Jagielloński, Wydział Zarządzania i Komunikacji Społecznej

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy